Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy

Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy

Background: Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) has been used to treat various peritoneal malignancies. Cisplatin and mitomycin C (MMC) are agents commonly used in these procedures and, individually, each has been associated with acute kidney injury (AKI). There is limited...

Full description

Bibliographic Details
Main Authors: Ravish Kapoor, Kristen Ashlee Robinson, Juan Pablo Cata, Pascal Owusu-Agyemang, Jose Miguel Soliz, Michael Hernandez, Paul Mansfield, Brian Badgwell
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:International Journal of Hyperthermia
Subjects:
intraperitoneal chemotherapy
hyperthermia
kidney injury
cisplatin
mitomycin c
Online Access:http://dx.doi.org/10.1080/02656736.2019.1597175

Internet

http://dx.doi.org/10.1080/02656736.2019.1597175

Similar Items